Merck & Co., Inc., products

CANCIDAS  is an echinocandin antifungal  indicated in  adults and pediatric patients (3 months of age and older) for: Empirical therapy for presumed fungal  infections in febrile, neutropenic patients.  Treatment of candidemia and the following Candida infections: intraabdominal abscesses, peritonitis and pleural space infections.  Treatment of esophageal candidiasis.  Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

CRIXIVAN (indinavir sulfate) is an inhibitor of the human immunodeficiency virus (HIV) protease. CRIXIVAN Capsules are formulated as a sulfate salt and are available for oral administration in strengths of 200 and 400 mg of indinavir (corresponding to 250 and 500 mg indinavir sulfate, respectively). Each capsule also contains the inactive ingredients anhydrous lactose and magnesium stearate. The capsule shell has the following inactive ingredients and dyes: gelatin and titanium dioxide.